Benzinga - Minneapolis Mayor Deprioritizes Psychedelics: 'We Should Be In The Business Of Helping People'
- Minneapolis Mayor Jacob Frey recently signed an executive order effectively deprioritizing criminal prosecution for possession, use, purchase, cultivation and engaging in practices with “entheogenic plants or plant compounds."
- The order also averts the use of local resources in support of federal and state actions against the substances “unless required by law.” The edict only applies to “natural” substances and excludes any synthetic ones. Moreover, it doesn’t refer to them as “psychedelics,” but instead as “naturally-occurring psychoactive compounds” or “entheogens.” Keep reading HERE.
- German company Acid Berlin is selling a reportedly legal LSD prodrug and shipping it through DHL Group (OTCMKTS: DHLGY) to clients based in Berlin.
- The company seems to be leaning on a legal loophole as Germany’s Narcotic Act (BtMG), the New Psychoactive Substances Act (NpSG) and the Drugs Act (AMG) do not explicitly prohibit 1D-LSD. Order amounts start at five or 10 and go up to no less than 500 for microdose capsules and 250 for either “extra-dose” pellets or “normal-dose” 150 microgram blotters. Read more HERE.
- Renowned rapper and fervent cannabis advocate Wiz Khalifa took center stage this week by throwing out the first pitch at a Pittsburgh Pirates baseball game. However, it did not take long for controversy to break out.
- In a couple of pre-game tweets, Khalifa hinted that cannabis — a given when it comes to Wiz — wasn't the only substance in his system at the time.
- As Green State spotted, before taking a stand on the mound the Pittsburgh native shared on Twitter: “Finna get stoned af and throw this first pitch at the pirates game." And about a minute later, he added an intriguing P.S.: "Shroomed out throwin a baseball is crazy." Keep reading HERE.
- Reunion Neuroscience (NASDAQ: REUN) is on the brink of going private with final court approval.
- Filament Health (OTCMKTS: FLHLF) gets ready to uplist to NASDAQ in a $210M SPAC deal.
- Sales of Johnson & Johnson (NYSE: JNJ) esketamine drug Spravato rose nearly 100% year-over-year.
- PharmaTher's (OTCMKTS: PHRRF) DMT patch showed positive outcomes, investment toward the clinical stage.
- Terran Biosciences stepped into 4-OH-DiPT prodrug arena with new patent application
- A quantum leap in psychedelic research: study shows real-time brain changes after ketamine use.
- Enveric Biosciences (NASDAQ: ENVB) unveiled positive results from animal studies of its psilocin prodrug for anxiety.
- Compatibility of psilocybin & SSRIs for depression, COMPASS Pathways (NASDAQ: CMPS) looks at 'psychedelic-assisted therapies'.
- Core One Labs (OTCMKTS: CLABF) entered a LOI for the first sale of its psychedelic biosynthetic compounds.
- A European project for precision psychiatry: this company is using AI to predict mental health disorders.
- Survey finds psychedelic support line is beneficial to users and healthcare system, a powerful harm reduction model.
- Learn about a new national accreditation system for psychedelic practitioners in this exclusive series.
- Here’s a list of psychedelics companies investors should get to know.
- 'Manson Girl' released from prison: a story about LSD, mind control, violence and the CIA's secret experiments.
Psychedelics ETF Weekly Performance AdvisorShares Psychedelics ETF (NYSEARCA: PSIL) opened Monday, July 24, at $1.94, dropping from prior Friday’s closing at $1.99. During the morning, the number dropped to $1.92, after which it began to gradually recover to the current $1.96.
On July 17, it opened at $2.04, essentially maintaining the previous Monday’s opening price.
The past week’s highest was on Tuesday, July 18, reaching $2.06, and lowest was on Thursday, July 20 at $1.95. Prior week’s lowest was $1.97 and highest was $2.06.
The ETF’s yearly price range is set between $4.35 and $1.65.
The Benzinga Cannabis Capital Conference Is Back! The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.